Dual-Porosity Hollow Carbon Spheres with Tunable Through-Holes for Multi-Guest Delivery
Source abstract
Abstract
Dual-porosity hollow carbon spheres (DPHCs) with small mesopores (2–4 nm) and large through-holes (20–30 nm) in shells were successfully synthesized using colloidal silica as the template, small silica nanoparticles as nanomasks, and nontoxic dopamine as the carbon precursor followed by post-carbonization and etching. The synthesized DPHCs were further oxidized to be hydrophilic and then used to simultaneously deliver the protein bovine serum albumin (21 × 4 × 14 nm3) and the small molecule doxorubicin (<1 nm), which exhibited a high loading capacity of 689.4 and 1421.2 mg/g, respectively. The release of these two guest molecules can be controlled independently under the stimuli of heat and acidity. In vitro and in vivo experiments also proved that the DPHCs are promising for the co-delivery of multiple cargoes of different sizes.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Mesoporous Materials and Catalysis · Porphyrin and Phthalocyanine Chemistry · Supercapacitor Materials and Fabrication
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Materials Science and State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai 200433, People’s Republic of China
Funding
Ministry of Science and Technology of the People's Republic of China · Shanghai Municipal Education Commission · Shanghai Education Development Foundation · National Natural Science Foundation of China · Shanghai Talent Development Fund
References (41)
Show source-provided references
1. 10.1002/slct.20170041710.1002/slct.201700417 ↗
2. 10.1021/cr068020s10.1021/cr068020s ↗
3. 10.1002/anie.20060448810.1002/anie.200604488 ↗
4. 10.1002/anie.20120884010.1002/anie.201208840 ↗
5. 10.1002/adfm.20100149510.1002/adfm.201001495 ↗
6. 10.1039/c0cc04909c10.1039/c0cc04909c ↗
7. 10.1021/la100455w10.1021/la100455w ↗
8. 10.1002/smll.20160428310.1002/smll.201604283 ↗
9. 10.1002/ente.20170039710.1002/ente.201700397 ↗
10. 10.1021/acsami.5b0258010.1021/acsami.5b02580 ↗
11. 10.1021/jacs.5b0152210.1021/jacs.5b01522 ↗
12. 10.1021/la200014w10.1021/la200014w ↗
13. 10.1039/C6CS00135A10.1039/C6CS00135A ↗
14. 10.1002/adfm.20140240810.1002/adfm.201402408 ↗
15. 10.1002/adma.20130218910.1002/adma.201302189 ↗
16. 10.1002/smll.20050003510.1002/smll.200500035 ↗
17. 10.1021/jacs.5b1172010.1021/jacs.5b11720 ↗
18. 10.1002/chem.20140613710.1002/chem.201406137 ↗
19. 10.1021/ja311687310.1021/ja3116873 ↗
20. 10.1002/anie.20100125210.1002/anie.201001252 ↗
21. 10.1021/am404709w10.1021/am404709w ↗
22. 10.1021/jacs.5b0320710.1021/jacs.5b03207 ↗
23. 10.1039/C6CS00829A10.1039/C6CS00829A ↗
24. 10.1002/anie.20100284910.1002/anie.201002849 ↗
25. 10.1002/adma.20150552410.1002/adma.201505524 ↗
26. 10.1039/C5CS00695C10.1039/C5CS00695C ↗
27. 10.1021/acs.chemmater.5b0396310.1021/acs.chemmater.5b03963 ↗
28. 10.1016/j.ijpharm.2013.01.05810.1016/j.ijpharm.2013.01.058 ↗
29. 10.1002/smll.20160205210.1002/smll.201602052 ↗
30. 10.1002/anie.20100069710.1002/anie.201000697 ↗
31. 10.1021/acsami.6b1163910.1021/acsami.6b11639 ↗
32. 10.1007/s40843-015-0037-210.1007/s40843-015-0037-2 ↗
33. 10.1039/b911083f10.1039/b911083f ↗
34. 10.1002/anie.20090261210.1002/anie.200902612 ↗
35. 10.1002/adma.20120392310.1002/adma.201203923 ↗
36. 10.1016/j.jcis.2012.07.03010.1016/j.jcis.2012.07.030 ↗
37. 10.1002/ange.20140762910.1002/ange.201407629 ↗
38. 10.1002/smll.20170040310.1002/smll.201700403 ↗
39. 10.1021/acs.chemmater.6b0260410.1021/acs.chemmater.6b02604 ↗
40. 10.1021/nn700040t10.1021/nn700040t ↗
41. 10.1039/C5CC01393C10.1039/C5CC01393C ↗